Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Polycystic Ovary Syndrome 139Breast Neoplasms 31Prostatic Neoplasms 29Insulin Resistance 28Obesity 19Pancreatic Neoplasms 13Neoplasms 12Infertility 12Endometrial Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Colorectal Neoplasms 11Anovulation 9Lung Neoplasms 8Metabolic Syndrome 7Melanoma 7Hyperandrogenism 7Glioblastoma 7Diabetes Mellitus 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Rectal Neoplasms 5Adenocarcinoma 5Weight Loss 4Urinary Bladder Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Carcinoma, Ovarian Epithelial 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Recurrence 3

Interventions

Cetuximab 2Alpelisib 2toripalimab 1raltitrexed 1cabozantinib 1Radiotherapy, Intensity-Modulated 1Metformin 1Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Head and Neck Squamous Cell Cancer × Metformin × Clear all
NCT02083692 2025-05-15

Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
50 enrolled
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡